CBIO
CBIO
KYG2545C1042
Crescent Biopharma, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
553.86M EUR
499.66M EUR
506.55M EUR
Enterprise Value
438.19M EUR
329.5M EUR
318.93M EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
-5.67x
--
--
Price to Sales
46.61x
42.05x
42.63x
Price to Book
3.13x
3.06x
2.76x
EV/Revenue
36.88x
27.73x
26.84x
EV/EBITDA
-2.58x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
--
-30.74%
-29.75%
ende